Literature DB >> 6170740

Reversal of experimental delayed cerebral vasospasm by angiotensin-converting enzyme inhibition.

H Gavras, P Andrews, N Papadakis.   

Abstract

Delayed cerebral vasospasm is an important determinant of the clinical outcome after subarachnoid hemorrhage, but its prevention and treatment has met with limited success. Since cerebral arteries were found to be sensitive to the vasoconstrictor effect of angiotensin II, the possibility of angiotensin's contribution to this vasospasm was investigated. Delayed cerebral arterial spasm was documented angiographically 72 hours after introduction of blood in the subarachnoid space of dogs. Following injection of the angiotensin-converting enzyme inhibitor, teprotide, repeat cineangiograms at 30, 60, and 90 minutes demonstrated partial or total release of spasm of the basilar artery and its branches. It is concluded that angiotensin II participates in the delayed cerebral vasospasm after hemorrhage, and that angiotensin inhibition may release the spasm and prevent cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170740     DOI: 10.3171/jns.1981.55.6.0884

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

1.  Effect of intracisternal thromboxane A2 analogue on cerebral artery permeability.

Authors:  M Zuccarello; T Sasaki; N F Kassell; M Yamashita
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

2.  Effect of GSH on cerebral vasospasm in dogs.

Authors:  S Haciyakupoğlu; F Ildan; S Polat; E Cetinalp; B Boyar; M Kaya
Journal:  Neurosurg Rev       Date:  1994       Impact factor: 3.042

3.  Angiotensin II receptor content within the subfornical organ and organum vasculosum lamina terminalis increases after experimental subarachnoid haemorrhage in rats.

Authors:  B Açikgöz; T Ozgen; F Ozdoğan; A Sungur; I H Tekkök
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

4.  Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: Experimental-Clinical Disconnect and the Unmet Need.

Authors:  Fumiaki Oka; David Y Chung; Michiyasu Suzuki; Cenk Ayata
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.210

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.